Article Details
Retrieved on: 2020-12-03 13:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
TAVO and KEYTRUDA led to a complete response in her treated lesions and ... <b>immune system</b> in patients with cancer refractory to available treatments. ... a late-stage <b>biotechnology</b> company focused on developing cytokine-based ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here